LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Assets, Equity Method Investments
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Deferred Tax Assets, Equity Method Investments of $0 as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsEquityMethodInvestments · last filed 2019-02-28
- 2018-12-31: Deferred Tax Assets, Equity Method Investments $0.00.
- 2017-12-31: Deferred Tax Assets, Equity Method Investments $5.14M.
- 2016-12-31: Deferred Tax Assets, Equity Method Investments $5.69M.
- 2015-12-31: Deferred Tax Assets, Equity Method Investments $1.84M.
| Period end | Deferred Tax Assets, Equity Method Investments |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2017-12-31 | $5.14M 10-K · filed 2019-02-28 |
| 2016-12-31 | $5.69M 10-K · filed 2018-03-01 |
| 2015-12-31 | $1.84M 10-K · filed 2017-02-28 |